Beth Israel Deaconess Medical Center 1
1. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
2. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
3. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
4. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
5. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
6. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
7. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinsons Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
8. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
9. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
10. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
11. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
12. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
13. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
14. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
15. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
16. TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
17. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
18. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants
19. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
1